A study to evaluate ecopipam tablets in patients with Tourette's disorder (H-53869)
Description
Content
A multicenter, open-label, study to evaluate the longterm safety of ecopipam tablets in children, adolescents and adults with Tourette's disorder
The purpose of this study is to learn about the long-term safety and tolerability of ecopipam in participants who completed the studies EBS-101-TD-301, EBS-101-OL-001, and PSY-302A.
Contact
Phone 1: 713–798–5989
IRB: H-53869
Status:
Active
Created:
